Skip to main content
Clinical Trials/NCT04437576
NCT04437576
Unknown
Not Applicable

Pregnancy and Latent Labor Biomarkers and Symptoms to Predict Cervical Dilation at Hospital Admission.

Oregon Health and Science University1 site in 1 country300 target enrollmentSeptember 13, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Labor Onset Biomarkers
Sponsor
Oregon Health and Science University
Enrollment
300
Locations
1
Primary Endpoint
Change in Interleukin-8 (IL-8) expression during latent phase of labor to delivery
Last Updated
5 years ago

Overview

Brief Summary

The proposed pilot investigation is a prospective, observational study of 300 healthy nulliparous women with spontaneous term labor onset. The specific aims of this study are to:

Aim #1: Characterize IL-8 (pro-inflammatory biomarker), basal body temperature, maternal heart rate, and electrical activity of the uterus prior to spontaneous onset of labor through the onset of active labor among nulliparous women. IL-8 will be quantified weekly, daily basal body temperature, as well as continuous maternal heart rate and electrical activity of the uterus throughout the transition from late pregnancy into active labor.

Aim #2: Characterize latent labor symptoms among nulliparous women in spontaneous labor. Using Likert scale, childbirth-specific, symptom-specific PROMIS measures,45 and open-ended questions will be quantified and characterize latent labor symptoms (e.g., intensity, frequency) and identify relevant themes.

Aim #3: Characterize trajectories of labor biomarkers and latent labor symptoms across latent labor duration. A modified growth mixture modeling approach to quantify subgroup phenotypes among nulliparous women in spontaneous latent labor will be employed.

Hypothesis 3.1. There will be significant congruence between higher biomarkers (e.g., higher IL-8, more uterine electrical activity) and symptoms that are more intense and frequent.

Hypothesis 3.2. At least two classes of laboring women with distinct trajectories of change in biomarkers and symptoms can be identified and will be associated with cervical dilation at hospital admission.

Exploratory Aim: Characterize biomarkers among nulliparous women with spontaneous labor onset vs. nulliparous women requiring labor induction for post-term gestation. Weekly IL-8, daily basal body temperature, as well as continuous maternal heart rate and electrical activity of the uterus throughout the transition from late pregnancy into active labor between those whose labor begins spontaneously and those whose labors are induced for post-term gestation will be quantified.

Exploratory Hypothesis. There will be different biomarker patterns between women with spontaneous labor onset vs. those without.

The Standard descriptive and inferential statistics as well as growth mixture modeling for quantitative aims will be used. The investigators will use thematic development for qualitative aims.

Registry
clinicaltrials.gov
Start Date
September 13, 2019
End Date
June 1, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ellen Tilden

Assistant Professor

Oregon Health and Science University

Eligibility Criteria

Inclusion Criteria

  • Nulliparous
  • Maternal age of at least 20 years of age.
  • Maternal age of no greater than 39 years of age.
  • Viable, term pregnancy: ≥ 37 weeks gestation at time of signing study consent.
  • Able to understand and provide an informed consent.
  • Able to understand English.

Exclusion Criteria

  • Multiple gestation (i.e., carrying \>1 fetus)
  • Managing complex comorbidities (e.g., preeclampsia)
  • Documented fetal congenital anomalies
  • Preterm labor and birth
  • Persistent breech fetal position at term
  • Fetal death prior to the onset of labor
  • Any indication for planned cesarean birth (e.g., placenta previa)
  • Induction of labor for medical indication (e.g., oligohydramnios)

Outcomes

Primary Outcomes

Change in Interleukin-8 (IL-8) expression during latent phase of labor to delivery

Time Frame: week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU

Measure of IL-8 in serum

Changes in Basal body temperature during latent phase of labor to delivery

Time Frame: Daily from 37 weeks gestation until admission to hospital for labor

Measure body temperature first thing every morning until admission to hospital for birth.

Change in Maternal heart rate during latent phase of labor to delivery

Time Frame: Continuously from 37 weeks gestation until admission to hospital for labor

Wearable sensor worn to record heart rate continually.

Change in electrical activity of the uterus during latent phase of labor to delivery

Time Frame: Continuously from 37 weeks gestation until admission to hospital for labor

Wearable sensor that records signals detected on the surface of the abdomen (e.g. signals generated by the uterus) and movements.

Secondary Outcomes

  • Characterize trajectories of latent labor symptoms across latent labor duration(week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU)
  • Characterize trajectories of latent labor biomarkers across latent labor duration(week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU)
  • Characterize latent labor symptoms among nulliparous women in spontaneous labor(week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU)

Study Sites (1)

Loading locations...

Similar Trials